Related Experiment Videos
Quebec Cooperative Study of Friedreich's ataxia. Cooperative Study, Phase Two: statement of the problems
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dominantly inherited ataxias in Portugal.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·1988
Linkage studies of Friedreich ataxia by means of blood-group and protein markers.
American journal of human genetics·1987
MPTP potentiates iron-induced lipid peroxidation without the involvement of free radicals derived from oxygen.
Research communications in chemical pathology and pharmacology·1987
Erythrocyte antioxidant activity in human patients with Parkinson's disease.
Neuroscience letters·1987
Cerebral Microbleeds and Superficial Siderosis: Vascular Correlates and Cognition in a Memory Clinic.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Symptom Trajectories and Postoperative Treatment Response After Surgical Repair of Spinal CSF Leaks.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Challenges and Care Recommendations of Persons with Functional Neurological Disorder and Care Partners: A Qualitative Study.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Machine learning-based prediction of Metabolic Syndrome risk in the Quebec population.
BMJ digital health & AI·2026
An RCA-Coupled CRISPR/Cas12a Cascade-Enhanced SERS Platform for Ultrasensitive Detection of Exosomal miRNA-21 in Colorectal Cancer Serum.
International journal of nanomedicine·2026
Smartphone-assisted dual-mode cyanide ion sensing in environmental and biological matrices using a triphenylamine-quinoline-conjugated chromogenic receptor.
Analytical methods : advancing methods and applications·2026
Multistep Continuous Flow Synthesis of 14C-Labeled cis/trans-Chrysanthemic Acid.
Journal of labelled compounds & radiopharmaceuticals·2026